期刊文献+

慢性心力衰竭患者血清N末端-脑钠肽前体水平检测分析 被引量:2

Analysis of N-terminal Pro-brain Natriuretic Peptide Levels in Patients with Chronic Heart Failure
下载PDF
导出
摘要 探讨慢性心力衰竭(CHF)患者血清N末端-脑钠肽前体(NT-proBNP)水平的变化及临床意义。择128例CHF患者为CHF组,20例无器质性心脏病者为对照组。所有受试者均采用NYHA分级法分级诊断心功能,电化学发光双抗体夹心免疫法检测血清NT-proBNP水平,心脏彩色多普勒超声测定左心室射血分数(LVEF)。对比CHF组与对照组的血清NT-proBNP水平,分析CHF患者血清NT-proBNP水平与NYHA心功能级别和LVEF的关系。结果显示:CHF患者血清NT-proBNP水平显著高于对照组(P<0.05),并随NYHA心功能级别增高而升高(P<0.05),随LVEF下降而升高(r=-0.595,P<0.05)。结论:血清NT-proBNP水平能较好地反映失代偿性CHF患者的心功能状态,有助于CHF的诊断和病情评估。 To investigate the changes and its clinical significance of serum N-terminal pro-brain natriuretic peptide(NT-proBNP) levels in patients with chronic heart failure(CHF),128 patients with decompensated CHF and 20 patients without structural heart disease were selected as CHF and control group.All subjects were evaluated heart function by New York Heart Association(NYHA) class.The serum NT-proBNP levels were assayed by electrochemiluminescence double antibody sandwich immunoassay.Left ventricular ejection fraction(LVEF) was detected by color Doppler ultrasound.The results showed that the NT-proBNP levels in CHF group were significantly higher than that of in the control group(P0.05).Further,the NT-proBNP levels showed an increased tendency accompanied by the severity of heart failure(P0.05) and lowering of LVEF(r=-0.595,P0.05).The serum NT-proBNP levels can reflect the state of cardiac function in patients with decompensated DHF,and useful in the diagnosis and severity assessment of CHF.
出处 《标记免疫分析与临床》 CAS 2011年第1期4-6,共3页 Labeled Immunoassays and Clinical Medicine
关键词 慢性心力衰竭 N末端-脑钠肽前体 电化学发光免疫法 Chronic heart failure N-terminal pro-brain natriuretic peptide Electro-chemiluminescence immunoassay
  • 相关文献

参考文献8

  • 1无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3698
  • 2Sata Y,Krum H.The future of pharmacological therapy for heart failure[J].Circ J,2010,74(5):809-817.
  • 3Palazzuoli A,Gallotta M,Quatrini I,et al.Natriuretic peptides (BNP and NT-proBNP):measurement and relevance in heart failure[J].Vasc Health Risk Manag,2010,1(6):411-418.
  • 4Moro C,Berlan M.Cardiovascular and metabolic effects of natriuretic peptides[J].Fundam Clin Pharmacol,2006,20(1):41-49.
  • 5赵昕,王萌.N端脑钠肽前体对心力衰竭诊断价值的研究[J].中国老年学杂志,2007,27(13):1287-1289. 被引量:51
  • 6Ordonez-Lianos J,Collinson P O,Christenson R H.Amino-terminal pro-B-type natriuretic peptide:analytic considerations[J].Am J Cardiol,2008,101(3A):9-51.
  • 7徐国宾,史晓敏.B型钠尿肽及N末端B型钠尿肽原在临床应用中值得关注的几个问题[J].中华检验医学杂志,2006,29(1):9-11. 被引量:71
  • 8Hildebrandt P,Collinson P O.Amino-terminal pro-B-type natriuretic peptide testing to assist the diagnostic evaluation of heart failure in symptomatic primary care patients[J].Am J Cardiol,2008,101(3A):25-28.

二级参考文献50

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:91
  • 2Richards AM,Nicholls MG,Yandle TG,et al.Plasma N-terminal probrain natriuretic peptide and adrenomedullin:new neurohormonal predictors of left ventricular dysfunction and prognosis after myocardial infarction[J].Circulation,1998 ;97(19):1921-9.
  • 3Remme WJ,Swdberg K.Guidelines for the diagnosis and treatment of chronic heart failure:task force report[J].Eur Heart,2001;22(7):1527-60.
  • 4Dessi-Fulgheri P,Sarzani R,Rappelli A.Role of the natriuretic peptide system in lipogenesis/lipolysis[J].Nutr Metab Cardiovasc Dis,2003;13(4):244-9.
  • 5McCullgh PA,Nowak RM,McCord J,et al.B-type natriuretic peptide and clinical judgment I emergency diagnosis of heart failure:analysis from breathing not properly (BNP) Multinational study[J].Circulation,2002;106(4):419-22.
  • 6Nakamura M,Endo H,Nasu M,et al.Value of plasma B-tupe natriuretic peptid emeasurement for heart disease screening in a Japanese population[J].Heart,2 002;87(2):131-5.
  • 7Seino Y,Ogawa A,Yamashita T,et al.Application of NT-proBNP and BNP measurements in cardiac care:a more discerning marker for the detection and evaluation of heart failure[J].Eur J heart Failure,2004;6(3):295-300.
  • 8Yeo KT,Wu AH,Apple FS,et al.Multicenter evaluation of the Roche NTproBNP assay and comparison to the Biosite triage BNP assay[J].Clin Chim Acta,2003;338(12):107-15.
  • 9Mair J,Hammer L,Puschendorf B,et al.The impact of cardiac natriuretis peptide determination on the diagnosis and management of heart failure[J].Clin Chem Lab Med,2001;39(7):571-88.
  • 10Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L

共引文献3811

同被引文献24

引证文献2

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部